Leukocytes, subjected once to interferon (IFN) induction by HVJ (Sendai virus), were studied for their capability to produce IFN after a second similar stimulus. Substantial amounts of IFN (about 30000 IU/ml) were recovered. Experiments using cycloheximide or actinomycin D and kinetic studies showed that this IFN originated mainly in IFN which resided within the cell as a result of the first induction and was released after the second stimulation. Increasing amounts of HVJ used for the second stimulus resulted in proportionally increased yields of IFN, reaching a plateau at the same dose of HVJ (1000 HAU/ml) as that which gave optimal yields after the first stimulation. Evidence is presented that the capacity of HVJ to trigger the production of a second IFN harvest is closely associated with its infectivity.
HVJ (Sendai Virus) Stimulates Release of Interferon from Leukocytes Used Once for Interferon Production
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SUMMARY Leukocytes, subjected once to interferon (IFN) induction by HVJ (Sendai virus), were studied for their capability to produce IFN after a second similar stimulus. Substantial amounts of IFN (about 30000 IU/ml) were recovered. Experiments using cycloheximide or actinomycin D and kinetic studies showed that this IFN originated mainly in IFN which resided within the cell as a result of the first induction and was released after the second stimulation. Increasing amounts of HVJ used for the second stimulus resulted in proportionally increased yields of IFN, reaching a plateau at the same dose of HVJ (1000 HAU/ml) as that which gave optimal yields after the first stimulation. Evidence is presented that the capacity of HVJ to trigger the production of a second IFN harvest is closely associated with its infectivity.
Interferon (IFN)-ct derived from leukocytes of healthy volunteers is produced at the Osaka Blood Center using the method of Mogensen & Cantell (1977) . Despite the advantages of this system, leukocytes are only available in limited quantity. Therefore, we investigated the possibility of re-use of the leukocytes for IFN production, and found that a second yield of about 30000 International Units (IU)/ml of IFN could be obtained.
The pooled buffy coat layers from healthy donors were centrifuged at 3000 r.p.m, for 9 min and the concentrated buffy coats were collected. They were haemolysed with cold 0.83 ~ NH4C1 (adjusted to neutral pH with NaHCO3) and then centrifuged at 800 r.p.m, for 10 min. The cells were again treated with NH4C1, then centrifuged as above and washed with Ham's F-12 medium (Nissui Seiyaku Co. Ltd., Japan). The purified leukocytes were suspended in the same medium containing 2~ human serum at a concentration of 1 x 10 v cells/ml and incubated at 37 °C for 2 h. HVJ (Sendai virus) was added (final concentration 100 HAU/ml) and the leukocytes were incubated for an additional 14 to 16 h. At the end of this period the supernatant fluid was harvested and the cells were collected by centrifugation at 4200 r.p.m, for 25 min. The cells were resuspended in Ham's F-12 medium for reculturing. The recultured cells were handled in a similar manner to the first culture with modifications of cell concentration and HVJ concentration (see below). After incubation, the supernatant fluid was harvested.
Titres of IFN were determined on human amnion (FL) cells by a cytopathic inhibition microassay method with vesicular stomatitis or Sindbis virus as a challenge virus. All titres were calibrated against the international IFN-ct reference (NIH G023-901-527) and are expressed as IU/ml. The human IFN-ct antiserum (NIH G026-502-568) was used to neutralize IFN activity. IFN samples (approx. 200 IU/ml) were serially diluted (twofold) and each dilution was mixed with an equal volume of antiserum. After incubation at 37 °C for 60 rain, the residual IFN activities were assayed as described above.
HVJ (provided by Dr T. Kishida, Cantell strain) was inoculated into embryonated eggs. Infected chorioallantoic fluids were purified by differential centrifugation and the HVJ was * Cycloheximide (CHI) and actinomycin D (Act D) Were added to the medium at final concentrations of 10 ~tg/ml and 5 ~tg/ml respectively. suspended in phosphate-buffered saline containing 5~ Plasmanate (Green Cross Co. Ltd., Osaka, Japan). They were stored at -80 °C until use. To inactivate H V J , the suspensions were exposed to u. Table 3 .
Effect of ~-propiolactone on various biological activities of H V J
/~-Propiolactone Untreated Treated Infectivity 3 × 10 ~° p.f.u./ml <1 × 102 p.f.u./ml Haemagglutinating activity 64000 HAU/ml 64000 HAU/ml IFN-~ inducing activity 65000 IU/ml 52000 IU/ml IFN-c~ release stimulating activity 25000 IU/ml 12000 IU/ml* * This value was the same as that obtained when no HVJ was added. ratio of 1:9. After mixing, and incubation at 0°C for 10min and at 37°C for 2h, the suspensions were held at 4 °C overnight. Infectivity of HVJ was determined on LLC-MK2 (monkey kidney) cells by plaque titration (Sugita et al., 1974) . I F N (29900 to 30000 IU/ml) was always obtained in the second culture of leukocytes which had been used once for IFN production. The addition of actinomycin D or cycloheximide to the second culture did not lead to the suppression of I F N production using doses which fully inhibited I F N production in the first culture (Table i) . Fig. 1 shows the IFN yields with varying times of HVJ addition. A rapid increase of I F N activity was observed within a few minutes after the addition of HVJ, whereas I F N activity increased only gradually without the addition of HVJ. Further HVJ addition to the first culture at the end of incubation also resulted in an increase (20 to 50~) of I F N yields. I F N yields in the second culture paralleled those obtained in the first culture ( Table 2 ), suggesting that I F N activity in the second culture was not due to de novo synthesis, but due to the liberation of I F N which had been synthesized and accumulated in cells upon stimulation by the first addition of HVJ. More than 9 7~ of this I F N activity was neutralized by anti-IFN-a antibody (data not shown).
As shown in Fig. 2 , the I F N activity increased proportionally to the amount of HVJ added, reaching a maximum level at about 1000 HAU/ml. When HVJ (1000 HAU/ml) was added as an inducer in the first cultures, I F N production was suppressed and no I F N activity was detected (data not shown).
An attempt was made to identify the function of HVJ involved in the release of IFN. Treatment of virus with fl-propiolactone resulted in loss of IFN-releasing activity together with the loss of infectivity; however, red cell agglutinating activity, I F N inducibility and cell fusion ability remained almost unchanged (Table 3 ). As shown in Table 4 , the infectivity of HVJ decreased linearly as a result of u.v. irradiation. A 15 s irradiation period was enough to cause complete loss of the ability to release IFN. These results indicate that the IFN-releasing activity of HVJ is closely associated with HVJ infectivity.
When different inducers such as concanavalin A or phytohaemagglutinin are used, IFN-7 is produced. Similar to these inducers, the addition of HVJ caused a substantial increase in IFN-~ yields as well as IFN-a (Table 5 ). The protein concentration in the culture medium was quite unchanged around the period of HVJ addition. Other reagents for membrane stimulation, such * Human leukocytes were suspended at 4 x 106/ml in Ham's F-12 medium containing 2~ human serum, and incubated for 2 h at 37 °C. Then concanavalin A (10 gg/ml) was added and the samples were incubated for 3 days. The second culture was performed in a way similar to the method used for IFN-c~ production, except that the cell concentration differed. IFN titres were determined on FL cells by a cytopathic inhibition microassay using Sindbis virus for challenge. 1FN-7 titres were calibrated against the international reference (NIH G023-901-530).
Short communication
as D E A E -d e x t r a n , A23187, polyethylene glycol or poly(I), poly(C) had no effects on the increase • of I F N titre.
Addition of the same amount of H V J as that used as an inducer in the first culture produced an I F N titre from 2 x 104 to 3 x 104 I U / m l (15 to 20% of the yield in the first culture), while the addition o f t e n times more H V J as had been used in the first induction resulted in a titre between 7 x 104 and 15 x 104 I U / m l , equivalent to that in the first culture. Although this m e t h o d uses large amounts of H V J for obtaining additional I F N and is therefore not practical for large-scale production, the m e c h a n i s m on the stimulatory effect of H V J on I F N release is worthy of further study.
The present study shows that in order to m a k e the best use of h u m a n leukocytes from donated blood, cells used once for I F N -~ production can be recovered and used again for I F N -~ production, since the H V J stimulated release of IFN-c~ already synthesized and present within the cells.
